Find out more about the Tailor Clinics Medical Weight Loss Program
Both groups exceeded 20%, indicating robust response regardless of sex
Weight loss effects of GLP-1RAs Liraglutide (3.0 mg, Saxenda), a GLP-1RA that activates the GLP-1 receptor, was approved by the FDA in December 2014 for adult obesity treatment [38] and has recently shown efficacy in adolescents aged 12 to 18 years
Here are eight takeaways from our conversation with Kessler about using the GLP-1 drugs, and the changing landscape of weight loss
Prescription GLP-1 receptor agonists produce sustained, supraphysiologic levels of GLP-1 activityfar exceeding what dietary modifications can achieve
Plateau Response Decision Guide Stall under 2 weeks: Continue current protocol, normal fluctuation Stall 2 to 4 weeks: Assess adherence, consider one minor adjustment Stall over 4 weeks, subtherapeutic dose: Escalate dose Stall over 4 weeks, full dose: Implement advanced strategies Long Term Weight Loss Expectations Setting realistic expectations for the full Retatrutide journey helps maintain motivation through inevitable fluctuations
